This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
See you next year! September 15-18, 2025
Hynes Convention CenterBoston, MA

James Blackwell
President and Principal Consultant at Windshire Group, LLC
Speaker

Profile

Dr. James Blackwell is President of Windshire Group, LLC, a global biopharmaceutical consulting firm, and is leading industry consultant on the development, quality, and manufacturing of therapeutics. His experience encompasses early process development to commercial operations for major therapeutic classes, and he has consulted to clients globally from start-ups to multi-nationals, and to major industry investors. He has held senior positions with Repligen, Genzyme, and Abbvie, where he was the site Head of Technical Operations. He served on the formative management team for several start-ups. As a member of ISPE, he has held leadership positions at the Chapter and National levels. He is also a member of ISCT, PDA, and AAPS. Dr. Blackwell has graduate training in chemical engineering, microbiology, and business/technology management from Northeastern University, The Ohio State University, and University of Maryland.

Agenda Sessions

  • CDMO Partnerships- Selection, Negotiation, Tech Transfer, Life Cycle Management for Cell & Gene Therapy Products

    9:00am
  • CDMO Partnerships- Selection, Negotiation, Tech Transfer, Life Cycle Management for Cell & Gene Therapy Products

    11:00am
  • CDMO Partnerships- Selection, Negotiation, Tech Transfer, Life Cycle Management for Cell & Gene Therapy Products

    1:00pm
  • CDMO Partnerships- Selection, Negotiation, Tech Transfer, Life Cycle Management for Cell & Gene Therapy Products

    3:00pm